UNICYCIVE THERAPEUTICS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2021-12-31 was $2.10M, a 14907.14% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $2.19M, a 7203.33% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $30.00K, a 0.00% change year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2020-12-31 was $14.00K.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2021 was $2.19M, a 2006.73% increase from fiscal 2020.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2020 was $104.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.19M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.19M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $30.00K 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $104.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $30.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $30.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |